Biologics
Proto Axiom Secures $20M in Series B to Strengthen Australia's Biotech IP Retention
Proto Axiom, the Australian biomedical technology incubator has today announced a $20 million first close of its targeted $30 million S...
August 13, 2024 | News
MSD to Acquire Curon Biopharma’s Investigational Bispecific Antibody CN201 in $1.3 Billion Deal
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, annou...
August 12, 2024 | News
Pioneering German Delegation, Led by Stem Cell Expert Prof. Mike Chan, Forges New Era of Sino-German Collaboration in Biotechnology
A landmark German delegation, led by world-renowned stem cell expert Prof. Dato' Sri Dr. Mike Chan, concluded a three-day visit to Baoding, China...
August 12, 2024 | News
Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...
August 12, 2024 | News
Twist Bioscience Expands DNA Synthesis Portfolio with Launch of Longer Gene Fragments up to 5.0kb
-Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform,...
August 09, 2024 | News
Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...
August 07, 2024 | News
Oxford Nanopore Partners with Singapore's NPM to Map Genomic Diversity of Major Ethnic Groups
Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precis...
August 05, 2024 | News
WuXi Biologics Secures EMA GMP Certification for Five Facilities in China
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities ...
August 02, 2024 | News
Innovent Biologics and Sanegene Bio USA Dose First Participant in Phase 1 Trial of Promising siRNA Hypertension Treatment
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
August 02, 2024 | News
Sirnaomics Forms Joint Venture with Gore Range Capital to Propel RNAi Therapeutics into Aesthetic Medicine
Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...
August 01, 2024 | News
$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...
July 31, 2024 | News
Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies
Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...
July 31, 2024 | News
Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...
July 30, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
